About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
The biopharmaceutical industry invests hundreds of billions of dollars annually in research and development (R&D) of new innovative medicines. Today’s sales of these medicines in countries around the world ultimately fund the R&D that was needed to create and bring them to market. New analysis from EY measures spending on new innovative medicines as a share of GDP per capita and shows that many high-income countries are not paying for these innovations proportionately to their wealth.
High-income Country Spending on Innovative Medicines
Report
High-income Country Spending on Innovative Medicines
High-income Country Spending on Innovative Medicines